Esperite

Esperite FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Esperite (ESP.AS) as of Nov 17, 2026 is 33.88 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 6.64 % — a change of 410.42% (higher).

FCF Conversion

33.88 %

YoY

410.42%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Esperite is 2017 33.88 % . FCF Conversion Rate (FCF/EBITDA) of Esperite was 2016 6.64 % . It decreases by 410.42% higher compared to the previous year.

The Esperite FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2014
96.57 EUR
Jan 1, 2015
35.75 EUR
Jan 1, 2016
6.64 EUR
Jan 1, 2017
33.88 EUR
The Esperite FCF Conversion history
YEARFCF ConversionYoY
33.88 %+410.42%
6.64 %-81.43%
35.75 %-62.98%
96.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Esperite Stock analysis

What does Esperite do? Esperite NV is a company based in the Netherlands that specializes in the development, production, and marketing of stem cell and cell therapies. It focuses on creating groundbreaking therapies for the treatment of serious diseases and aims to market them worldwide. Its business model includes three main segments: Life Science, Consumer Healthcare, and Branding. The Life Science segment focuses on developing stem cell and cell therapies for the treatment of diseases such as autism, cancer, and degenerative disorders. The Consumer Healthcare segment offers products related to pregnancy and fertility assistance. The Branding segment involves the development and marketing of high-quality cosmetic products. Esperite's flagship product is CryoSave, a solution for the long-term preservation of stem cells from umbilical cord blood. Esperite is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Esperite stock

FCF Conversion Rate (FCF/EBITDA) of Esperite is 33.88 % in 2017.

FCF Conversion Rate (FCF/EBITDA) of Esperite changed from 6.64 % to 33.88 %, representing a 410.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Esperite since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Esperite with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Esperite

All Key Metrics — Esperite